Drug Test (Urine, Blood, Saliva and Hair Screening): What It Detects and What It Cannot

Key takeaways

• Exposure, not impairment: A positive drug test indicates a substance was present above a cut-off, not that the person was impaired at the time of testing.
• Screening is provisional: Immunoassay screens produce false positives; confirmation by GC-MS or LC-MS/MS is required before a result is treated as final.
• Sample type decides the window: Saliva and blood reflect recent use, urine an intermediate period, hair a longer historical period.
• A negative is not proof of abstinence: Use outside the detection window, low levels below the cut-off, or a drug not on the panel will all read negative.
• Panels are limited: A standard panel tests only for listed substances. Many newer synthetic drugs are not included.

At a glance

Also known as

• Drug screen, drug abuse panel, drug of abuse (DOA) screen
• Urine drug screen (UDS), urine drug test
• Narcotic test, "nasha test" in common Indian usage
• Toxicology screen (broader, used in hospital emergency settings)
• Dope test (sports/anti-doping usage)

What a drug test is

A drug test is a laboratory or point-of-care analysis that looks for particular drugs, or the metabolites the body produces from those drugs, in a biological sample. The test is targeted: the laboratory searches only for the substances included in the ordered panel.

Most testing has two stages. The first stage is an immunoassay screen, which is fast and inexpensive but works by antibody cross-reaction, so chemically similar compounds can trigger it. The second stage is a confirmatory test using gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), which identifies the specific molecule. A screen-positive result that has not been confirmed should not be treated as a final answer.

Each drug has a cut-off concentration. Below the cut-off, the result is reported as negative even if trace amounts are present. Cut-offs are set deliberately to avoid reporting incidental traces, and they differ between laboratories and between workplace, clinical and forensic programmes.

Why a drug test is done

• Clinical toxicology: In a patient with altered consciousness, seizures, unexplained agitation or suspected poisoning, a drug screen may help narrow the possibilities alongside clinical examination and other investigations.
• Addiction and de-addiction care: To support treatment planning and monitor progress during recovery, used as a clinical tool rather than a punishment.
• Opioid and controlled-medicine monitoring: In pain or psychiatry practice, to check whether a prescribed medicine is being taken and whether unexpected substances are present.
• Workplace safety: Pre-employment or periodic screening, particularly in transport, mining, aviation, heavy industry and some healthcare roles.
• Legal and forensic: Under court direction, or as part of investigations. Forensic samples require a documented chain of custody.
• Sport: Anti-doping testing is a separate regulated system with its own prohibited list, accredited laboratories and sample-handling rules. Routine hospital drug panels are not anti-doping tests.

Who should get this test

• People brought to an emergency department with unexplained drowsiness, confusion, agitation, pinpoint or dilated pupils, or suspected overdose.
• Individuals in a de-addiction or rehabilitation programme, as agreed with the treating team.
• Patients on long-term opioids, benzodiazepines or stimulant medicines where the prescriber has advised monitoring.
• Candidates or employees in safety-critical occupations where an employer policy requires testing.
• People required to be tested by a court, licensing body or probation authority.
• Competitive athletes within a formal anti-doping programme.

A drug test is not a general health screening test and is not part of a routine master health check-up. Testing an adult without informed consent, outside a lawful emergency or a legal directive, raises consent and privacy issues. Where testing is clinically necessary in an unconscious patient, this is handled under emergency care principles and documented.

What a drug test cannot detect or exclude

This is the part most often misunderstood, so it is set out plainly.

• It cannot measure impairment. Presence of a metabolite does not mean the person is under the influence now. Cannabis metabolites in particular can persist long after any effect has worn off.
• It cannot tell you when the drug was taken. A urine result does not distinguish use last night from use three days ago.
• It cannot tell you how much was taken. Concentration is influenced by hydration, metabolism, kidney function, body composition and time since use.
• It cannot diagnose addiction or dependence. Substance use disorder is a clinical diagnosis based on history, pattern of use and functional impact, not on a laboratory result.
• It cannot detect drugs outside the ordered panel. Standard panels frequently miss synthetic cannabinoids, many designer stimulants, newer benzodiazepines, fentanyl analogues, gabapentinoids, ketamine and most sedative-hypnotics unless specifically requested.
• It cannot reliably detect alcohol beyond a short period unless a specific marker such as ethyl glucuronide is ordered.
• A negative result does not exclude drug use. "Not detected" means not detected in this sample, by this method, above this cut-off. If clinical concern persists despite a negative result, return to the doctor, do not treat the negative as a clearance.
• Hair testing cannot establish a precise date of use and cannot reliably detect very recent use in the last few days, because hair takes time to grow out from the scalp.

Related but different examinations

These tests answer different questions. None is universally superior. The right sample depends on why the test is being done: blood or oral fluid for recency, urine for a broad panel, hair for a longer retrospective view.

How to prepare

Preparation requirements, collection protocols and accepted sample volumes are set by each laboratory and by the programme requesting the test. Your collection centre's written instructions take precedence over any general guidance.

• Fasting is not required for drug screening.
• Bring a full medicine list: prescription medicines, over-the-counter products, AYUSH and herbal preparations, and gym or bodybuilding supplements. Several of these can interfere with screening immunoassays.
• Do not stop or alter any prescribed medicine to influence a test. Speak to the prescriber first. Abruptly stopping certain medicines can be dangerous.
• Carry photo identification if the test is for employment or legal purposes. Chain-of-custody collections require identity verification.
• Normal hydration only. Drinking large volumes of water to "flush" a sample usually produces a dilute specimen, which many programmes treat as an invalid or refused test rather than a negative.
• For hair testing, tell the collector about bleaching, colouring, chemical straightening or very short hair, as these affect collection and interpretation.

If you have heart failure, advanced kidney disease or a fluid restriction

Do not increase fluid intake to produce a urine sample. Tell the collection staff about your condition. Extra fluid loading can be harmful in these situations, and an alternative sample or a longer wait can be arranged.

If you have diabetes on glucose-lowering treatment

No fasting is needed for a drug test, so continue your usual meals and medicines as prescribed. If you have been asked to fast for other tests on the same visit, discuss the timing of insulin or sulfonylureas with your doctor beforehand to avoid hypoglycaemia.

If you are pregnant

Testing in pregnancy should be done with informed consent and as part of supportive care, not as a punitive exercise. Discuss with the obstetric team how the result will be used, who will see it, and what help is available.

Children and adolescents

Testing a minor requires parental or guardian consent alongside age-appropriate explanation, except in an emergency where testing guides urgent treatment. Covert testing of a teenager by a parent damages trust and rarely helps; a conversation with a paediatrician or adolescent health specialist is more useful.

Older adults

Multiple prescribed medicines increase the chance of cross-reaction on screening assays. Reduced kidney function can alter how long metabolites remain detectable. Provide a complete medicine list.

What happens during a drug test

• Urine: You provide a sample in a supplied container in a designated washroom. In chain-of-custody or supervised collections, taps may be taped, dye added to the cistern, and personal belongings kept outside. Temperature is checked immediately to confirm the sample is fresh. Direct observation is used only where a programme specifically requires it.
• Blood: A trained phlebotomist draws blood from an arm vein into designated tubes.
• Oral fluid: An absorbent swab is held in the mouth or between cheek and gum until enough fluid is collected. You will usually be asked not to eat, drink or smoke for a short period before collection.
• Hair: A small bundle of hair is cut close to the scalp, usually from the crown. Body hair may be used if scalp hair is unavailable, though the interpretation differs.
• Sweat patch: A patch is applied to clean skin and worn for a set period, then removed and sent for analysis.

How long the process takes

• Collection: Usually five to fifteen minutes. Chain-of-custody paperwork and identity checks add time.
• Point-of-care screening kits: Results in minutes, but these are preliminary only.
• Laboratory screening and confirmatory mass spectrometry: Turnaround depends on whether the sample is processed in-house or sent to a reference laboratory, and on whether confirmation is required. Confirmatory testing always takes longer than screening. Ask your collection centre for its own expected timeline.
• Hair analysis: Generally the slowest, as it needs specialised processing.

Understanding your report

A drug test report does not have a "normal range" in the way a haemoglobin or sugar report does. Results are reported against a cut-off.

• Negative / Not detected: The substance was not present above the cut-off in this sample. This is not the same as proof of no use.
• Positive / Detected: The substance or its metabolite was present above the cut-off. If this came from a screening immunoassay alone, it is presumptive and requires confirmation.
• Confirmed positive: Identity verified by mass spectrometry. This is the result that carries weight.
• Dilute: Creatinine and specific gravity suggest the urine is unusually dilute. Many programmes require a repeat sample.
• Adulterated or substituted: Validity testing found abnormal pH, oxidants or other markers inconsistent with human urine.
• Invalid: The sample could not be analysed reliably; a fresh sample is needed.

Cut-off concentrations and detection windows vary by laboratory, by assay and by the substance concerned, and the figures quoted on general websites often do not match the laboratory that ran your test. Read the cut-offs printed on your own report. Results must be interpreted in clinical and situational context by the doctor or authorised medical review officer who requested the test, never from the printout alone. Results vary depending on individual clinical circumstances.

When results can be misleading

Falsely positive: screen suggests a drug that was not used

• Cross-reaction on immunoassay is the commonest cause. Some cough, cold and decongestant preparations, certain antidepressants, some antipsychotics, quinolone antibiotics, proton pump inhibitors and a number of other prescription medicines have been reported to cross-react with particular assays.
• Prescribed opioids, benzodiazepines or stimulant medicines will legitimately produce a positive result, this is an expected finding, not misuse, and should be declared before testing.
• Poppy-seed intake has been associated with opiate-positive screens.
• Herbal, AYUSH and imported gym supplements may contain undeclared pharmacologically active compounds. This is a recognised problem and a common source of unexplained positives in India.
• Passive exposure is an uncommon but debated cause for cannabis at low cut-offs.

Mass spectrometry confirmation resolves most false positives, because it identifies the actual molecule rather than a structural family.

Falsely negative: drug used but not detected

• Use occurred outside the detection window for that sample type.
• Concentration fell below the cut-off, often because of dilution from heavy fluid intake.
• The drug is not on the panel, a frequent issue with synthetic and designer substances, fentanyl analogues and some newer benzodiazepines.
• Deliberate adulteration or substitution of the sample.
• Delayed transport, poor storage or degradation of the sample.
• Hair testing may miss use in the last few days, and heavy cosmetic hair treatment can reduce detectable drug content.

Risks and safety

Urine, oral fluid and hair collection

These collections are non-invasive. Hair collection removes a small bundle of hair and may leave a barely visible thin patch. Discomfort is minimal. The main burdens are the loss of privacy during supervised collection and the consequences attached to the result, not physical harm.

Blood sampling

Venepuncture can cause brief pain, bruising, or a small haematoma. Fainting occurs in some people. Infection at the puncture site is uncommon. Tell the phlebotomist if you take blood thinners or bruise easily.

Sweat patch

Skin irritation or a rash under the adhesive can occur. Tell staff about adhesive allergies or skin conditions.

Non-physical risks

Drug testing carries employment, legal, custodial and reputational consequences, and results are sensitive personal data. Under the Digital Personal Data Protection Act 2023, handling of such data requires lawful basis and appropriate safeguards. Ask who will receive your result, in what form, and how it will be stored before you consent.

Special situations

Pregnancy

Substance use in pregnancy affects both the pregnant person and the baby, and early engagement with care improves outcomes. Testing should be consent-based and linked to treatment and support. Neonatal testing of meconium or urine may be considered where there is clinical concern about withdrawal in the newborn, and is decided by the neonatal team.

Chronic kidney disease

Reduced kidney function alters the excretion and urinary concentration of many drugs and metabolites, which can affect both detectability and apparent concentration. Do not force fluids to produce a sample if you have a fluid restriction.

Liver disease

Impaired hepatic metabolism can change which metabolites appear and in what proportion, which occasionally complicates interpretation in opioid monitoring.

People on prescribed controlled medicines

Declare prescriptions before the sample is taken, not after the result arrives. An unexpected absence of a prescribed medicine on a monitoring test is also clinically meaningful and should be discussed openly with the prescriber rather than left unexplained.

Psychiatric illness

Several psychotropic medicines cross-react with screening assays. Never stop psychiatric medication before a test; speak to the treating psychiatrist.

Drug testing in the Indian context

• Terminology: Patients and employers commonly say "nasha test", "dope test" or "narcotic test". Laboratories list it as a drug of abuse panel or urine drug screen.
• Legal framework: The Narcotic Drugs and Psychotropic Substances Act 1985 governs controlled substances in India. Forensic testing for legal purposes follows prescribed procedures and chain-of-custody requirements; a routine hospital screen performed without that documentation is not equivalent to a forensic test.
• Data protection: The Digital Personal Data Protection Act 2023 applies to the handling of drug test results and any online booking or consent forms.
• Supplements and herbal products: Gym supplements, weight-loss products and some traditional preparations sold in India have been found to contain undeclared stimulants or sedatives. These are a genuine and under-recognised source of unexpected positive screens, and also of drug-induced liver injury.
• Panel availability: Broad panels, quantitative confirmation by LC-MS/MS and hair analysis are not available at every centre and are often referred to specialised reference laboratories. Confirm availability before booking.
• Anti-doping: Testing of competitive athletes in India is conducted through the national anti-doping framework, which uses its own accredited laboratory system. Hospital drug panels do not substitute for it.
• Access to treatment: Government de-addiction centres and a national toll-free substance use helpline operate in India; a treating doctor can direct you to the nearest service.

Cost and insurance in India

Costs in ? vary widely and no single figure applies nationally. Factors that influence what you pay:

• Number of analytes: A 5-panel screen costs considerably less than a 10- or 12-panel.
• Method: Point-of-care kits are cheapest; immunoassay laboratory screens sit in the middle; GC-MS or LC-MS/MS confirmation is substantially more expensive.
• Sample type: Hair analysis is typically the most expensive; urine the least.
• Qualitative versus quantitative: Reporting a numeric concentration costs more than a yes/no result.
• Chain of custody: Documented forensic collection, tamper-evident sealing and medical review officer involvement add cost.
• Setting and urgency: Emergency, after-hours and stat processing cost more than routine outpatient testing. Referral to an external reference laboratory adds charges.
• City and sector: Metro private laboratories generally charge more than smaller-city or government facilities.

Insurance: Health insurance in India generally covers investigations only when medically necessary and, for most policies, during an admissible hospitalisation. Pre-employment, legal, custody-related and sports testing is usually treated as non-medical and paid by the employer, the requesting authority or the individual. Many policies also contain exclusions relating to substance use. Check your policy wording and confirm the current price with the laboratory before testing.

Myths and facts

Frequently asked questions

Does a positive drug test mean I am addicted?

No. A positive drug test shows a substance was present above a cut-off in that sample. Substance use disorder is a clinical diagnosis based on pattern of use, loss of control, craving and effect on daily life. A doctor makes that assessment through consultation, not from a laboratory report.

Can my prescribed medicines make the test positive?

Yes. Prescribed opioids, benzodiazepines and stimulant medicines will legitimately appear. Some antidepressants, antipsychotics, cold remedies and antibiotics can cross-react with screening immunoassays. Declare every medicine, supplement and herbal product before the sample is taken. Do not stop any prescribed medicine, speak to your prescriber.

How long do drugs stay detectable?

Detection windows differ by substance, dose, frequency of use, metabolism and sample type. Blood and saliva generally reflect recent use, urine an intermediate period, and hair a much longer historical period. There is no single reliable number for any drug, and published figures are estimates rather than guarantees.

Do I need to fast before a drug test?

Fasting is not required for drug screening. For oral fluid collection you may be asked to avoid eating, drinking or smoking for a short period beforehand. If other blood tests are being done at the same visit, follow the instructions your collection centre gives for those.

What is the difference between a screening test and a confirmatory test?

A screening immunoassay is rapid and inexpensive but detects chemical families, so unrelated compounds can trigger it. Confirmatory GC-MS or LC-MS/MS identifies the specific molecule and its concentration. A screen-positive result should be confirmed before any employment, legal or clinical decision is taken.

Can I refuse a drug test?

Adults can generally decline a test, but refusal may carry consequences under an employment contract, a court order or a sporting programme, and many programmes treat refusal as equivalent to a positive result. Testing in a medical emergency where the patient cannot consent follows emergency care principles.

My screen was positive but I have never used drugs. What now?

Ask whether the result was a screen or a confirmed mass-spectrometry result. Request confirmatory testing. Provide a complete list of medicines, supplements and herbal products to the reviewing doctor. Cross-reactivity and undeclared ingredients in supplements are recognised causes of unexpected screen positives.

Is a hospital drug test the same as a legal or sports test?

No. Forensic and anti-doping tests require documented chain of custody, tamper-evident sealing, specified laboratories and defined review procedures. A routine clinical screen ordered for medical care does not meet those standards and cannot substitute for a legally or competitively valid test.

Can a drug test detect alcohol?

Standard drug panels usually do not include alcohol. Alcohol is measured by breath analysis or a blood alcohol level for recent intake, or by specific markers such as ethyl glucuronide for a somewhat longer window. These must be requested specifically.

Sources

• Narcotic Drugs and Psychotropic Substances Act, 1985, Government of India
• Digital Personal Data Protection Act, 2023, Government of India
• World Anti-Doping Agency, International Standard for Testing and Investigations, and the annual Prohibited List
• National Institute on Drug Abuse, resources on drug testing and substance use disorder
• Substance Abuse and Mental Health Services Administration, Mandatory Guidelines for Federal Workplace Drug Testing Programs (urine, oral fluid and hair)
• National Drug Dependence Treatment Centre, AIIMS New Delhi, clinical resources on substance use disorders
• Ministry of Social Justice and Empowerment, Government of India, National Action Plan for Drug Demand Reduction